Hence, a total of 29 NMOSD patients seropositive for AQP4 autoantibodies were identified by cell-based IIFA, and 20 of these 29 patients (69%) were seropositive for NMO-IgG by tissue-based IIFA. Here, AQP4 is linked to neuromyelitis optica.